Viome partners with Ezaki Glico: target for Ezaki Glico stock is JPY 3,900

Ezaki Glico (ISIN JP3161200005) is expanding into personalized nutrition after announcing a Japanese mRNA health service with Viome on September 14, 2026. The service targets 50,000 customers by 2030, while Investing.com lists an average 12-month analyst target of JPY 3,900 for the stock.

Personalized health adds a new growth line

According to MarketScreener on September 14, 2026, the mRNA HEALTH TRACKER combines Viome's gut microbiome analysis with Glico's consumer guidance and nutrition products. The program is designed to turn test results into 26 personalized health indicators and recommendations.

The commercial target matters because the initiative is larger than a product launch. The planned 50,000-customer base by 2030 would give Glico a measurable route into recurring health services, although the source describes the current phase as distribution and data collection.

Overseas operations lift early profit

ENVALITH reports that first-quarter 2026 net sales reached JPY 85,277 million, up 10.30 percent from the prior year, while operating profit rose 40.70 percent to JPY 3,697 million. Overseas revenue increased 26.90 percent to JPY 26,447 million, making international operations the clearest quantified growth driver.

The same first-quarter account puts the full-year 2026 sales forecast at JPY 380,000 million and operating profit forecast at JPY 14,000 million. Progress reached 22.40 percent of the sales target and 26.40 percent of the operating profit target, so profit was advancing faster than revenue at that stage.

Target remains below the market price

Investing.com lists two analyst ratings, both Sell, and an average 12-month target of JPY 3,900.00. The same page gives a Tokyo Stock Exchange 52-week range of JPY 4,685.00 to JPY 6,290.00 and a next earnings date of November 6, 2026.

That target sits below the quoted October 6, 2026 Tokyo Stock Exchange price of JPY 5,028.00, while the growth figures point to a divided picture: overseas expansion is accelerating, but the valuation still reflects expectations for stronger future earnings.

Prior close and Tokyo range

The prior close at Lang & Schwarz was EUR 28.30 on October 5, 2026. On the Tokyo Stock Exchange, Ezaki Glico stood at JPY 5,028.00 on October 6, 2026, within a 52-week range of JPY 4,685.00 to JPY 6,290.00. The further course of trading is shown by the continuously updated real-time quote of Ezaki Glico stock.

More news and analyses on Ezaki Glico stock